(Press-News.org) LA JOLLA, CA – October 9, 2013 - Scientists at The Scripps Research Institute (TSRI) have created a synthetic molecule that mimics "good" cholesterol and have shown it can reduce plaque buildup in the arteries of animal models. The molecule, taken orally, improved cholesterol in just two weeks.
This research, published in the October issue of Journal of Lipid Research, points scientists toward a new method for treating atherosclerosis, a condition where plaque buildup in the arteries can cause heart attacks and strokes.
"Atherosclerosis is the number one killer in the developed world," said TSRI Professor M. Reza Ghadiri, senior author of the new study with TSRI Assistant Professor of Chemistry Luke Leman. "This research clears a big step toward clinical implementation of new therapies."
Good vs. Bad Cholesterol
To combat atherosclerosis, researchers are looking for new ways to target and remove low-density lipoprotein (LDL) cholesterol (commonly known as "bad" cholesterol) from the body. Though the body needs some LDL to stay healthy, high levels lead to dangerous plaque buildups. In contrast, high-density lipoprotein (HDL) cholesterol ("good" cholesterol) is known for its protective effects.
"HDL is like a taxi in the bloodstream; it takes the LDL cholesterol out of the blood and delivers it to the liver," said Yannan Zhao, a postdoctoral researcher in Ghadiri's lab and first author of the new study. From the liver, the LDL is packaged for elimination from the body.
Using a method reported by the researchers last year in the Journal of the American Chemical Society, the team created a "nanopeptide" to have three arm-like structures that can wrap around cholesterol and fats in the blood.
Once the synthetic peptide wraps around LDL cholesterol, it removes it by mimicking the behavior of apoA-1, a protein of HDL, and carrying it to the liver for elimination.
A Surprising Finding
In collaboration with Linda Curtiss, formerly a faculty member at TSRI, and Bruce Maryanoff, formerly at Johnson & Johnson and currently a visiting scholar at TSRI, the researchers tested this synthetic peptide in a mouse model prone to atherosclerosis.
The team originally used the synthetic peptide in an experiment the researchers thought was a gamble. They gave it to mice in their drinking water, but assumed their digestive acids might break down the peptide before it got a chance to interact with its target and modify LDL cholesterol. To their surprise, it worked.
After 10 weeks of treatment, the mice had a 40 percent reduction in potentially harmful cholesterol in their blood and a 50 percent reduction in the size of plaque lesions in their hearts.
"We were definitely surprised at the results in the oral feeding studies," said Leman. "We've repeated it many times."
Many cholesterol treatments currently in development rely on an injection, not a pill. With the option of an orally effective peptide, Ghadiri believes researchers are closer to developing an accessible new therapy for atherosclerosis.
The researchers also reported no signs of increased inflammation in the blood or toxicity after 10 weeks of the peptide treatment.
Future Studies Point to Gut
Ghadiri and his team are now investigating exactly how the synthetic peptide works in the intestines and the possibility that it interacts with beneficial microbes. The researchers believe that finding new targets in the gastrointestinal tract could lead to new therapies for many more diseases.
"That's one of the fun things in science—now we get to follow up on these different avenues," said Leman.
In addition to Ghadiri, Leman, Zhao, Curtiss and Maryanoff, other contributors to the study, "In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-1," are Audrey S. Black and David J. Bonnet of TSRI.
INFORMATION:
Support for this study came from the National Institutes of Health (HL104462 and HL118114) and the American Heart Association Western States Affiliate. For access to this study, see http://www.jlr.org/content/55/10/2053.full; the Journal of Lipid Research also published a commentary on the work, available at http://www.jlr.org/content/55/10/1983
Large numbers of fish will disappear from the tropics by 2050, finds a new University of Britsh Columbia study that examined the impact of climate change on fish stocks. The study identified ocean hotspots for local fish extinction but also found that changing temperatures will drive more fish into the Arctic and Antarctic waters.
Using the same climate change scenarios as the Intergovernmental Panel on Climate Change, researchers projected a large-scale shift of marine fish and invertebrates. In the worst-case scenario, where the Earth's oceans warm by three degrees ...
Using a recently developed biomarker of aging known as an epigenetic clock, UCLA researchers working closely with a German team of investigators have found for the first time that obesity greatly accelerates aging of the liver. This finding could explain the early onset of many age-related diseases, including liver cancer, in obese subjects
Although it had long been suspected that obesity ages a person faster, it hadn't been possible to prove the theory, said study first author Steve Horvath, a professor of human genetics at the David Geffen School of Medicine at UCLA ...
The ideal cost per dose for a new meningitis vaccine ranges from £3 up to a possible £22 only if several vaccine favourable factors all coincide, according to research which has analysed how to maximise the reduction in cases while making a new vaccination programme cost-effective.
Bexsero is the first vaccine to broadly protect against meningitis B disease, but research now suggests the Government would need to negotiate a considerable reduction in the £75 list price in order to provide the same value for money as other programmes in the NHS.
In March ...
Proteins regulating cell division determine tumour growth. Ongoing clinical trials are currently studying inhibitors for two of these proteins, Cdk4 and Cdk6, targeting several types of cancer, such as breast cancer, lung cancer and leukaemia. The Cell Division and Cancer Group at the Spanish National Cancer Research Centre (CNIO), led by Marcos Malumbres, has discovered the molecular mechanism behind the interaction of these proteins. Researchers also demonstrated in mice that the simultaneous inhibition of both molecules is more effective than the individual inhibition. ...
Focusing on large, star-forming galaxies, researchers at the Johns Hopkins University were able to measure radiation leaks in an effort to better understand how the universe evolved as the first stars were formed.
Sanchayeeta Borthakur, an assistant research scientist in the Department of Physics and Astronomy in the university's Krieger School of Arts and Sciences, reports in a paper published online Oct. 9 in the journal Science that an indicator used for studying star-forming galaxies that leak radiation is an effective measurement tool for other scientists to use. ...
(PHILADELPHIA) – Some cancers, like breast and prostate cancer, are driven by hormones such as estrogen and testosterone, but to date, there are none that are driven by the lack of a hormone. New evidence suggests that human colon cells may become cancerous when they lose the ability to produce a hormone that helps the cells maintain normal biology. If verified by further studies, it suggests that treating patients at high risk for colon cancer by replacing the hormone guanylin could prevent the development of cancer.
The researchers at Thomas Jefferson University ...
PHILADELPHIA — Higher levels of total cholesterol and triglycerides, two types of fat, in the blood of men who underwent surgery for prostate cancer, were associated with increased risk for disease recurrence, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
"While laboratory studies support an important role for cholesterol in prostate cancer, population-based evidence linking cholesterol and prostate cancer is mixed," said Emma Allott, PhD, postdoctoral associate at Duke ...
Intensive parenting and health education provided in homes of pregnant American Indian teens reduced the mothers' illegal drug use, depression and behavior problems, and set their young children on track to meet behavioral and emotional milestones they may have otherwise missed.
The Johns Hopkins Bloomberg School of Public Health-led research also suggests that employing local community health educators instead of more formally educated nurses to counsel young at-risk mothers could be cost effective and provide badly needed jobs to high school graduates from the same ...
Adoption of a combination of five key healthy behaviors is associated with a reduction in the risk of developing bowel cancer. Researchers from the German Institute of Human Nutrition Potsdam-Rehbruecke quantified the impact of combined multiple healthy lifestyle behaviors on the risk of developing bowel cancer, and found that this impact is stronger in men than in women.
Lead author, Krasimira Aleksandrova, says: "These data provide additional incentive to individuals, medical professionals and public health authorities to invest in healthy lifestyle initiatives. Each ...
The sanitation intervention delivered under the terms of the Government of India's Total Sanitation Campaign—the world's largest sanitation initiative—provided almost 25 000 individuals in rural India with access to a latrine. However, it did not reduce exposure to faecal pathogens or decrease the occurrence of diarrhoea, parasitic worm infections, or child malnutrition.
"The programme is effective in building latrines, but not all households participate"*, explains lead author Professor Thomas Clasen from Emory University, Atlanta, USA and the London School ...
